Four months after GSK settled a key case in California over its heartburn medication Zantac, AstraZeneca is following suit, agreeing to resolve personal injury claims over its heartburn drugs Nexium ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...

Add Yahoo as a preferred source to see more of our stories on Google. Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney ...

(RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The ...

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

LOS ANGELES Extreme complications from Type 1 diabetes and renal failure put 55-year-old Danny Parr in the hospital. But medical exams revealed he also has significant coronary artery disease, so he's ...

FDA officials say it will need three months to thoroughly analyze data on possible cardiac risk associated with Nexium and Prilosec, both proton pump inhibitors used to treat heartburn and reflux ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

WASHINGTON — U.S. regulators said Monday that they had cleared AstraZeneca’s bestselling heartburn drugs Prilosec and Nexium of links to heart problems, but disclosed a review of a potential risk of ...

correctionA May 8 article misstated the amount of money spent in 2004 advertising the heartburn medication Nexium. The correct figure is $200 million, not $2.2 million. (Published 5/19/2005) Beginning ...

Oct. 3 (UPI) --Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn ...